Methodology: Two hundred T2DM patients on standard glucose lowering agents and who may be on lipid and blood pressure lowering agents were followed up for 2 years for improvement in CV risk markers like BMI, HbA1c, systolic blood pressure(S-BP), diastolic BP(D-BP), total cholesterol(TC), HDL, non-HDL, LDL, triglycerides(TG), cholesterol remnant(CR), highly-sensitive CRP(hsCRP), serum creatinine(Cr) and eGFR. T2DM patients with recent history of re-vascularisation or any major surgery were excluded. At the end of 2 years, NT-proBNP was measured as an assessment tool for residual CV risk. Those with higher NT-proBNP(>=125) were identified and patient level characteristics as described above were analysed and compared to patients with NT-proBNP <125. Data was analysed using SPSS version 20, represented as Mean + 2(SD) with 95% CI, descriptive statistics and independent t test was used and p-value of less than 0.was considered statically-significant (Si)>.

Results: Baseline characteristics of patients with elevated NT-pro-BNP were: 40(54.05%) males and 34 (45.9%) females, mean age 63.54 ± 10.61 years, mean age since diagnosis 13.5 ± 7.3 years and mean BMI 29.41 ± 5.32 kg/m2. The mean values at the end of 2 years in patients with elevated NT-proBNP were: HbA1c 6.7 ± 1.13, S-BP 132.24 ± 27.5, D-BP 72.93 ± 17.14, TC 140.22 ± 48.98, LDL 70.57 ± 32.95, TG 131.13 ± 91.37, HDL 38.8 ± 13.02, non-HDL 90.18 ± 37.44, CR 23.11 ± 17.7, Cr 1.01 ± 0.29, eGFR 79.29 ± 25.2, hsCRP 4.09 ± 0.51,. There was Si difference seen with regard to Age(p-0.039), weight(p-0.015), D-BP(p-0.016), non-HDL(p-0.05), Cr(p-0.001), eGFR(0.001) at 2 years in patients with elevated NT proBNP compared to those with normal levels.

Conclusion: Patients with elevated NT-proBNP were older, had greater D-BP, TC, LDL, TG, non HDL, CR, Cr and weight and lower HDL and eGFR compared to patients without elevated NT pro BNP at 2 year.


V. Gupta: None. V. Teli: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at